Your browser doesn't support javascript.
loading
Canadian Contraception Consensus (Part 3 of 4): Chapter 8 - Progestin-Only Contraception.
Black, Amanda; Guilbert, Edith; Costescu, Dustin; Dunn, Sheila; Fisher, William; Kives, Sari; Mirosh, Melissa; Norman, Wendy; Pymar, Helen; Reid, Robert; Roy, Geneviève; Varto, Hannah; Waddington, Ashley; Wagner, Marie-Soleil; Whelan, Anne Marie.
Afiliação
  • Black A; Ottawa ON (Co-Chair).
  • Guilbert E; Quebec QC (Co-Chair).
  • Costescu D; Hamilton ON.
  • Dunn S; Toronto ON.
  • Fisher W; London ON.
  • Kives S; Toronto ON.
  • Mirosh M; Saskatoon SK.
  • Norman W; Vancouver BC.
  • Pymar H; Winnipeg MB.
  • Reid R; Kingston ON.
  • Roy G; Montréal QC.
  • Varto H; Vancouver BC.
  • Waddington A; Kingston ON.
  • Wagner MS; Montréal QC.
  • Whelan AM; Halifax NS.
J Obstet Gynaecol Can ; 38(3): 279-300, 2016 03.
Article em En | MEDLINE | ID: mdl-27106200
ABSTRACT

OBJECTIVE:

To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality.

OUTCOMES:

Overall efficacy of cited contraceptive methods, assessing reduction in pregnancy rate, safety, ease of use, and side effects; the effect of cited contraceptive methods on sexual health and general well-being; and the relative cost and availability of cited contraceptive methods in Canada. EVIDENCE Published literature was retrieved through searches of Medline and The Cochrane Database from January 1994 to January 2015 using appropriate controlled vocabulary (e.g., contraception, sexuality, sexual health) and key words (e.g., contraception, family planning, hormonal contraception, emergency contraception). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies published in English from January 1994 to January 2015. Searches were updated on a regular basis in incorporated in the guideline to June 2015. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. VALUES The quality of the evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table 1). CHAPTER 8 PROGESTIN-ONLY CONTRACEPTION Summary Statements Recommendations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progestinas / Anticoncepção / Serviços de Saúde Reprodutiva Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment / Observational_studies / Prognostic_studies Limite: Female / Humans / Pregnancy País como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progestinas / Anticoncepção / Serviços de Saúde Reprodutiva Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment / Observational_studies / Prognostic_studies Limite: Female / Humans / Pregnancy País como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article